Skip to main content
TipRanks
Go Ultimate75% OFF

Protect Pharmaceutical (PRTT) Financial Statements

18 Followers

Protect Pharmaceutical Financial Overview

Protect Pharmaceutical's market cap is currently $3.44M. The company's EPS TTM is $0.86; its P/E ratio is -160.33; Protect Pharmaceutical has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 132.26M$ 136.16M$ 81.80M$ 78.79M$ 5.94M
Gross Profit$ 72.56M$ 73.31M$ 41.58M$ 44.37M$ 5.86M
Operating Income$ 57.64M$ 47.54M$ 25.26M$ 27.88M$ 5.81M
EBITDA$ 57.64M$ 47.71M$ 25.49M$ 28.11M$ 5.81M
Net Income$ 56.33M$ 45.91M$ 22.44M$ 20.21M$ 5.81M
Balance Sheet
Cash & Short-Term Investments$ 73.94M$ 65.11M$ 46.59M$ 77.40M$ 74.49K
Total Assets$ 417.63M$ 366.36M$ 344.45M$ 366.25M$ 20.01M
Total Debt$ 3.83M$ 3.79M$ 2.66M$ 12.32M$ 14.07M
Net Debt$ -13.83M$ -14.42M$ 1.46M$ -27.57M$ 14.00M
Total Liabilities$ 84.94M$ 90.00M$ 114.47M$ 160.61M$ 14.13M
Stockholders' Equity$ 332.69M$ 276.36M$ 229.98M$ 205.64M$ 5.89M
Cash Flow
Free Cash Flow$ 10.19M$ 0.00$ -69.02M$ -64.90M$ -13.03M
Operating Cash Flow$ 12.71M$ 4.04M$ -67.20M$ 10.51M$ 6.77M
Investing Cash Flow$ -3.92M$ 12.88M$ 46.06M$ 17.63M$ -19.80M
Financing Cash Flow$ 38.00K$ 1.60M$ -9.67M$ -5.05M$ 13.10M

Currency in USD

Protect Pharmaceutical Earnings and Revenue History

-80M080M160M0 %40 %80 %120 %EarningsProfit Margin2017201920202021202220232024RevenueEarningsProfit Margin

Protect Pharmaceutical Liabilities to Assets

0150M300M450M0 %25 %50 %75 %LiabilitiesLiabilities to Assets2017201920202021202220232024AssetsLiabilitiesLiabilities to Assets

Protect Pharmaceutical Cash Flow

-75M-50M-25M025M50M75M2017201920202021202220232024OperatingInvestingFinancing

Protect Pharmaceutical Forecast EPS vs Actual EPS